Cyclerion Therapeutics Inc.
CYCN | NASDAQ
$23.52
$0.00 (0.00%)
Nov 2, 2026, 11:28 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.9M | 1.99M | 2.07M | 2.86M | 2.17M | 2.08M | 2M | 194K | n/a | n/a | n/a | n/a | n/a | 306K | 1.02M | 1.55M | 1.9M | 4.59M | 3.94M | 3.54M | 3.6M | 1.34M |
Cost of Revenue | 730K | 730K | n/a | n/a | n/a | 105K | 149K | 149K | 729K | 963K | 1.49M | 2.27M | 1.69M | 11.57M | 20.74M | 30.42M | 37.45M | 39.29M | 29.54M | 31.18M | 37.85M | 25.8M |
Gross Profit | 1.17M | 1.26M | 2.07M | 2.86M | 2.17M | 1.98M | 1.85M | 45K | -729K | -963K | -1.49M | -2.27M | -1.69M | -11.26M | -19.72M | -28.87M | -35.55M | -34.7M | -25.6M | -27.64M | -34.25M | -24.45M |
Operating Income | -6.82M | -6.73M | -4.97M | -3.63M | -3.76M | -3.47M | -3.63M | -5.93M | -10.81M | -11.29M | -12.95M | -15.61M | -14.11M | -25.68M | -35.39M | -45.27M | -52.04M | -54.78M | -55.19M | -60.08M | -70.57M | -74.07M |
Interest Income | 117K | 132K | 128K | 117K | 129K | 160K | 208K | 281K | 346K | 346K | 358K | 389K | 393K | 376K | 288K | 156K | 45K | n/a | n/a | n/a | 93K | 231K |
Pretax Income | -6.71M | -5.28M | -3.53M | -2.2M | -1.95M | -2.94M | -3.06M | -5.28M | -10.47M | -10.95M | -12.59M | -15.22M | -13.72M | -25.31M | -35.1M | -41.55M | -48.43M | -51.22M | -51.65M | -60.1M | -67.62M | -70.97M |
Net Income | -6.71M | -5.28M | -3.53M | -2.2M | -1.95M | -2.94M | -3.06M | -5.28M | 3.01M | 149K | -5.26M | -10.79M | -28.85M | -38.05M | -44.08M | -47.64M | -48.43M | -51.22M | -51.65M | -60.1M | -67.62M | -70.97M |
Selling & General & Admin | 7.13M | 7.07M | 6.09M | 5.99M | 5.7M | 5.27M | 5.34M | 6.07M | 6.96M | 7.2M | 8.33M | 10.04M | 11.01M | 13.01M | 14.26M | 14.99M | 16.49M | 19.21M | 20.62M | 23.47M | 26.9M | 27.29M |
Research & Development | 1.6M | 1.65M | 959K | 496K | 229K | 278K | 286K | 254K | 753K | 987K | 1.52M | 2.67M | 3.5M | 13.38M | 22.55M | 31.83M | 37.45M | 39.29M | 37.64M | 39.27M | 45.94M | 47.68M |
Other Expenses | -730K | -730K | n/a | n/a | n/a | -105K | -149K | -349K | 2.38M | 2.14M | 1.61M | 637K | -2.09M | -11.97M | -21.14M | -30.42M | -37.45M | -38.41M | -28.66M | -30.3M | -36.52M | -25.35M |
Operating Expenses | 7.99M | 7.99M | 7.05M | 6.49M | 5.93M | 5.44M | 5.48M | 5.97M | 10.08M | 10.33M | 11.46M | 13.34M | 12.43M | 14.42M | 15.67M | 16.4M | 16.49M | 20.09M | 29.59M | 32.44M | 36.32M | 49.62M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 6K | 12K | 16K | 19K | 14K | 8K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 200K | 200K | 200K | 200K | 400K | 400K | 400K | 400K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.72M | 8.72M | 7.05M | 6.49M | 5.93M | 5.55M | 5.63M | 6.12M | 10.81M | 11.29M | 12.95M | 15.61M | 14.11M | 25.99M | 36.41M | 46.82M | 53.94M | 59.37M | 59.14M | 63.62M | 74.17M | 75.42M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 607.29K | 600.71K | 460.71K | 460.71K | 438.71K | 365.14K | 363.7K | 360.86K | 358.57K | 356.29K | 353.45K | 347.86K | 326K | 310.86K | 310.85K | 295.22K | 295.22K | 295.22K | 294.41K | 309.22K | 255.05K | 243.44K |
Shares Outstanding (Diluted) | 607.29K | 600.71K | 460.71K | 460.71K | 438.71K | 365.14K | 363.7K | 360.86K | 358.57K | 356.29K | 353.45K | 347.86K | 326K | 310.86K | 310.85K | 295.22K | 295.22K | 295.22K | 294.41K | 309.22K | 255.05K | 243.44K |
EPS (Basic) | -12.04 | -9.94 | -8.54 | -5.32 | -5.25 | -8.19 | -8.61 | -14.84 | -36.33 | -45.43 | -62.86 | -80.71 | -91.98 | -124.39 | -146.58 | -160.58 | -162.33 | -180.53 | -191.59 | -241.15 | -286.65 | -321.65 |
EPS (Diluted) | -12.04 | -9.94 | -8.54 | -5.32 | -5.25 | -8.19 | -8.61 | -14.84 | -36.33 | -45.43 | -62.86 | -80.71 | -91.98 | -124.39 | -146.58 | -160.58 | -162.33 | -180.53 | -191.59 | -241.15 | -286.65 | -321.65 |
EBITDA | -6.71M | -5.28M | -3.53M | -2.2M | -1.95M | -2.94M | -3.06M | -5.26M | -7.24M | -7.7M | -9.33M | -11.98M | -13.69M | -25.27M | -35.03M | -41.43M | -48.26M | -50.07M | -50.28M | -58.31M | -67.82M | -71.7M |
EBIT | -6.71M | -5.28M | -3.53M | -2.2M | -1.95M | -2.94M | -3.06M | -5.28M | -7.27M | -7.75M | -9.4M | -12.02M | -13.72M | -25.31M | -35.1M | -41.55M | -48.43M | -50.33M | -50.75M | -59.2M | -69.25M | -73.63M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16.25K | 32.5K | 48.75K | 65K | 48.75K | 32.5K | 33.25K | 65K | 113K | 161K | 262K | 472K | 894K | 1.43M | 1.93M |
Add to Watchlist
Select watchlists to add or remove CYCN